Perez Hilton has struggled with weight management for decades. Now, he’s spreading the word about the benefits of GLP-1 drugs ...

Questions about insurance coverage for weight-loss drugs are getting more intense as cheaper alternatives go off the market.

Novo Nordisk has experienced a 50% drop due to potential tariffs and recent clinical trial results. Read why I rate NVO stock a strong buy right now.

The average weight for women in the U.S. is 170.8 pounds, and the average height is 5 feet, 3 inches tall. These are mathematical calculations, so they don’t necessarily represent what’s typical or ...

In the past year, treatments such as Wegovy, Mounjaro and Zepbound have become household names. But there are many questions ...

Parfumdreams and DataPulse Research analyzed data that shows more and more Americans are "explanting" or removing their ...

Taking medications like Ozempic and Wegovy may lead to more hair loss than other weight loss drugs, new research found.

SaveHealth explores what the research says about Ozempic's effects on insulin resistance and related conditions.

Novo Nordisk is taking aim at Eli Lilly with a new obesity drug deal. Meanwhile, a survey shows doctors’ perception of the ...

Spending growth for simple medications used to treat common health problems is outstripping spending growth for pricey medications used to treat complex and chronic conditions, according to a new ...

Hims & Hers has risen since November 2024, outperforming the S&P 500. Click here to see why HIMS stock is a Buy.

Grammy Award-winning singer Meghan Trainor, 31, is flaunting a slimmer figure these days, leaving fans shocked at her ...